Urinary 6β-hydroxycortisol: a validated test for evaluating drug induction or drug inhibition mediated through CYP3A in humans and in animals M. M. GalteauF. Shamsa Review Article 06 November 2003 Pages: 713 - 733
Controlled withdrawal of selective serotonin reuptake inhibitor drugs in elderly patients in nursing homes with no indication of depression Johanna UlfvarsonJohanna AdamiChrister von Bahr Clinical Trials 01 November 2003 Pages: 735 - 740
The effect of long-term microcrystalline chitosan therapy on plasma lipids and glucose concentrations in subjects with increased plasma total cholesterol: a randomised placebo-controlled double-blind crossover trial in healthy men and women Saara MetsoRitva YlitaloTerho Lehtimäki Clinical Trials 07 November 2003 Pages: 741 - 746
Hormonal counterregulation and consecutive glimepiride serum concentrations during severe hypoglycaemia associated with glimepiride therapy A. HolsteinA. PlaschkeE.-H. Egberts Pharmacodynamics 22 November 2003 Pages: 747 - 754
Population pharmacokinetics of gentamicin in South African newborns J. H. BothaM. J. du PreezM. Adhikari Pharmacokinetics and Disposition 18 October 2003 Pages: 755 - 759
Effect of the novel anxiolytic drug deramciclane on the pharmacokinetics and pharmacodynamics of the CYP3A4 probe drug buspirone Kari LaineOuti AhokoskiJuha Rouru Pharmacokinetics and Disposition 18 October 2003 Pages: 761 - 766
Evaluation of the safety of bupropion (Zyban) for smoking cessation from experience gained in general practice use in England in 2000 Andrew BoshierLynda V. WiltonSaad A. W. Shakir Pharmacoepidemiology and Prescription 13 November 2003 Pages: 767 - 773
Comparison of chlorzoxazone one-sample methods to estimate CYP2E1 activity in humans Iza KramerKim DalhoffHenrik E. Poulsen Short Communication 11 November 2003 Pages: 775 - 778
A case of rhabdomyolysis with fatal outcome after a treatment with levofloxacin Fabrice PetitjeansJulien NadaudBruno Pats Short Communication 24 October 2003 Pages: 779 - 780
Increase in dihydroxycarbamazepine serum levels in patients co-medicated with oxcarbazepine and lamotrigine N. GuénaultP. OdouH. Robert Letter to the Editors 24 October 2003 Pages: 781 - 782